Tue, February 7, 2023
Mon, February 6, 2023
Sun, February 5, 2023
Fri, February 3, 2023

Matthew Sykes Maintained (CDNA) at Strong Buy with Decreased Target to $29 on, Feb 6th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-29-on-feb-6th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Sykes of Goldman Sachs, Maintained "CareDx, Inc" (CDNA) at Strong Buy with Decreased Target from $40 to $29 on, Feb 6th, 2023.

Matthew has made no other calls on CDNA in the last 4 months.



There are 2 other peers that have a rating on CDNA. Out of the 2 peers that are also analyzing CDNA, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Andrew Cooper of "Raymond James" Maintained at Strong Buy with Decreased Target to $24 on, Tuesday, January 31st, 2023
  • Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $28 on, Monday, November 7th, 2022

Publication Contributing Sources